Gewurz Benjamin E

32PUBLICATIONS
110CO-AUTHORS
Cellular nervous systemInnate immunityHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 16, 2026
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse.

|Aug 13, 2026
A tonsil organoid model reveals Epstein-Barr virus-infected germinal center B cell states during primary infection.

|Jun 15, 2026
Arginine metabolism supports de novo pyrimidine biosynthesis to block DNA damage and maintain Epstein-Barr virus latency.

|May 14, 2026
EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers.

|Apr 10, 2026
CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

Eric M Burton, Yifei Liao, Davide Maestri

|Feb 10, 2026
Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer.

Sarah Preston-Alp, Yin Wang, Matteo Bergonzoni

Pageof 6

Frequent Collaborators

6 joint publications

Mingxiang Teng

6 joint publications

Bo Zhao

6 joint publications

Rui Guo

4 joint publications

Yifei Liao